ES2031529T3 - Procedimiento de preparacion de sistemas coloidales dispersables de una substancia bajo la forma de nanocapsulas. - Google Patents

Procedimiento de preparacion de sistemas coloidales dispersables de una substancia bajo la forma de nanocapsulas.

Info

Publication number
ES2031529T3
ES2031529T3 ES198787402998T ES87402998T ES2031529T3 ES 2031529 T3 ES2031529 T3 ES 2031529T3 ES 198787402998 T ES198787402998 T ES 198787402998T ES 87402998 T ES87402998 T ES 87402998T ES 2031529 T3 ES2031529 T3 ES 2031529T3
Authority
ES
Spain
Prior art keywords
solvent
substance
nanocapsules
constituted
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787402998T
Other languages
English (en)
Spanish (es)
Inventor
Hatem Fessi
Francis Puisieux
Jean-Philippe Devissaguet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique
Original Assignee
Centre National de la Recherche Scientifique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique filed Critical Centre National de la Recherche Scientifique
Application granted granted Critical
Publication of ES2031529T3 publication Critical patent/ES2031529T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
ES198787402998T 1986-12-31 1987-12-28 Procedimiento de preparacion de sistemas coloidales dispersables de una substancia bajo la forma de nanocapsulas. Expired - Lifetime ES2031529T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8618444A FR2608942B1 (fr) 1986-12-31 1986-12-31 Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules

Publications (1)

Publication Number Publication Date
ES2031529T3 true ES2031529T3 (es) 1992-12-16

Family

ID=9342495

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787402998T Expired - Lifetime ES2031529T3 (es) 1986-12-31 1987-12-28 Procedimiento de preparacion de sistemas coloidales dispersables de una substancia bajo la forma de nanocapsulas.

Country Status (9)

Country Link
US (1) US5049322A (enExample)
EP (1) EP0274961B1 (enExample)
JP (1) JPH0693998B2 (enExample)
AT (1) ATE74025T1 (enExample)
CA (1) CA1293170C (enExample)
DE (1) DE3777793D1 (enExample)
ES (1) ES2031529T3 (enExample)
FR (1) FR2608942B1 (enExample)
GR (1) GR3004198T3 (enExample)

Families Citing this family (200)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
IE66912B1 (en) * 1988-02-05 1996-02-07 Schering Ag Ultrasonic contrast agents process for their preparation and their use as diagnostic and therapeutic agents
JP2670680B2 (ja) * 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
DE68904483T2 (de) * 1988-06-30 1993-05-19 Centre Nat Rech Scient Verfahren zur herstellung von kolloidalen dispergierbaren proteinsystemen, wie nanopartikeln.
WO1990013361A1 (en) * 1989-05-04 1990-11-15 Southern Research Institute Improved encapsulation process and products therefrom
FR2649888B1 (fr) * 1989-07-18 1994-08-26 Exsymol Sa Produits pour applications cutanees, a effets cosmetiques ou/et therapeutiques
FR2659554B1 (fr) * 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
USRE39146E1 (en) 1990-04-02 2006-06-27 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US6613306B1 (en) 1990-04-02 2003-09-02 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US5578292A (en) 1991-11-20 1996-11-26 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US20040208826A1 (en) * 1990-04-02 2004-10-21 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US7083778B2 (en) * 1991-05-03 2006-08-01 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
US6989141B2 (en) * 1990-05-18 2006-01-24 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US20010024638A1 (en) * 1992-11-02 2001-09-27 Michel Schneider Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
IN172208B (enExample) 1990-04-02 1993-05-01 Sint Sa
FR2660193B1 (fr) * 1990-04-03 1994-11-04 Philippe Maincent Produit opthalmique comportant des nanocapsules, son procede de preparation et utilisation des nanocapsules.
US20030194376A1 (en) * 1990-05-18 2003-10-16 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
AU636481B2 (en) * 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
IT1243390B (it) * 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
US6391343B1 (en) 1991-01-15 2002-05-21 Hemosphere, Inc. Fibrinogen-coated particles for therapeutic use
US5616311A (en) * 1991-01-15 1997-04-01 Hemosphere, Inc. Non-crosslinked protein particles for therapeutic and diagnostic use
ATE147976T1 (de) * 1991-01-15 1997-02-15 Hemosphere Inc Protein nanomatrizen und verfahren zur herstellung
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5609878A (en) * 1991-06-05 1997-03-11 Gueyne; Jean Insecticide composition of rotenone microspheres
FR2677223B1 (fr) * 1991-06-05 1997-06-06 Jean Gueyne Composition insecticide a base de rotenone, notamment pour le traitement des parasites humains et animaux.
ES2034891B1 (es) * 1991-08-08 1993-12-16 Cusi Lab Procedimiento de elaboracion en continuo de sistemas coloidales dispersos, en forma de nanocapsulas o nanoparticulas.
FR2681248B1 (fr) * 1991-09-13 1995-04-28 Oreal Composition pour un traitement cosmetique et/ou pharmaceutique de longue duree des couches superieures de l'epiderme par une application topique sur la peau.
CA2078388A1 (en) * 1991-10-02 1993-04-03 Mridula Nair Biocompatible emulsion particles
US5288502A (en) * 1991-10-16 1994-02-22 The University Of Texas System Preparation and uses of multi-phase microspheres
IL104084A (en) * 1992-01-24 1996-09-12 Bracco Int Bv Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them
FR2692168B1 (fr) * 1992-06-16 1995-03-24 Centre Nat Rech Scient Préparation et utilisation de nouveaux systèmes colloïdaux dispersibles à base de cyclodextrine, sous forme de nanosphères.
FR2692167B1 (fr) * 1992-06-16 1994-09-16 Centre Nat Rech Scient Préparation et application de nouveaux systèmes colloïdaux nanovésiculaires dispersibles à base de cyclodextrine, sous forme de nanocapsules.
WO1999000113A1 (en) * 1997-06-27 1999-01-07 Vivorx Pharmaceuticals, Inc. Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
ES2070076B1 (es) * 1993-04-20 1996-04-16 Cusi Lab Metodo para aumentar la estabilidad de las nanocapsulas durante su almacenamiento.
ES2070778B1 (es) * 1993-10-07 1995-12-16 Vinas Lab Composicion de liposomas y su procedimiento de obtencion.
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
PL182223B1 (pl) * 1993-12-15 2001-11-30 Bracco Research Sa Biokompatybilna faza rozproszona do otrzymywania srodka kontrastowego do badan ultradzwiekowych, srodek kontrastowy do badan ultradzwiekowych, suchy preparat srodka kontrastowego oraz dwuskladnikowy zestaw do otrzymywania srodka kontrastowego do badan ultradzwiekowych PL PL PL
JPH07246329A (ja) * 1994-03-09 1995-09-26 Nippon Paint Co Ltd マイクロカプセルの製造方法及びマイクロカプセル
ES2078190B1 (es) * 1994-05-20 1996-08-01 Cusi Lab Procedimiento para el recubrimiento de goticulas o particulas de tamaño nanometrico.
US5718922A (en) * 1995-05-31 1998-02-17 Schepens Eye Research Institute, Inc. Intravitreal microsphere drug delivery and method of preparation
US6143211A (en) * 1995-07-21 2000-11-07 Brown University Foundation Process for preparing microparticles through phase inversion phenomena
US6248720B1 (en) 1996-07-03 2001-06-19 Brown University Research Foundation Method for gene therapy using nucleic acid loaded polymeric microparticles
JPH11510142A (ja) 1995-07-21 1999-09-07 ブラウン・ユニバーシティ・リサーチ・ファンデーション 核酸負荷ポリマー微粒子を使用した遺伝子治療法
US6391338B1 (en) * 1995-09-07 2002-05-21 Biovail Technologies Ltd. System for rendering substantially non-dissoluble bio-affecting agents bio-available
US5922403A (en) * 1996-03-12 1999-07-13 Tecle; Berhan Method for isolating ultrafine and fine particles
EP1683517A1 (en) 1996-08-19 2006-07-26 American Bioscience, Inc. Methods for the production of protein particles useful for delivery of pharmacological agents
US20070092563A1 (en) 1996-10-01 2007-04-26 Abraxis Bioscience, Inc. Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US5945126A (en) * 1997-02-13 1999-08-31 Oakwood Laboratories L.L.C. Continuous microsphere process
US6264988B1 (en) 1997-06-05 2001-07-24 Hemosphere, Inc. Fibrinogen-coated microspheres
UA72189C2 (uk) 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
US7323179B2 (en) * 1997-12-19 2008-01-29 Naomi Balaban Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
WO1999033558A1 (en) * 1997-12-29 1999-07-08 Universite De Geneve Method for producing an aqueous colloidal dispersion of nanoparticles
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US6013122A (en) * 1998-08-18 2000-01-11 Option Technologies, Inc. Tattoo inks
DE19845078A1 (de) * 1998-09-30 2000-04-06 Basf Ag Farbstoffhaltige Polymerpartikel
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
US8236352B2 (en) 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
AU6283299A (en) * 1998-10-01 2000-04-17 Elan Pharma International Limited Controlled release nanoparticulate compositions
US6270802B1 (en) 1998-10-28 2001-08-07 Oakwood Laboratories L.L.C. Method and apparatus for formulating microspheres and microcapsules
US6428814B1 (en) * 1999-10-08 2002-08-06 Elan Pharma International Ltd. Bioadhesive nanoparticulate compositions having cationic surface stabilizers
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
AU775879C (en) * 1998-11-20 2005-03-10 Freedom-2, Inc. Permanent, removable tissue markings
FR2787730B1 (fr) 1998-12-29 2001-02-09 Oreal Nanocapsules a base de poly(alkylene adipate), leur procede de preparation et compositions cosmetiques ou dermatologiques les contenant
FR2787729B1 (fr) * 1998-12-29 2001-01-26 Oreal Nanocapsules a base de polymeres anioniques hydrodispersibles, leur procede de preparation et compositions cosmetiques ou dermatologiques les contenant
US6204308B1 (en) 1999-03-01 2001-03-20 Novartis Ag Organic compounds
FR2790405B1 (fr) * 1999-03-02 2001-04-20 Oreal Nanocapsules a base de polymeres dendritiques
KR20000074515A (ko) * 1999-05-21 2000-12-15 윤종용 액정표시장치 및 그의 화상 신호 전송 배선 형성 방법
US20090104273A1 (en) * 1999-06-22 2009-04-23 Elan Pharma International Ltd. Novel nifedipine compositions
ATE427743T1 (de) 1999-11-15 2009-04-15 Biocure Inc Auf aussere bedingungen ansprechende polymere hohle partikel
FR2805761B1 (fr) * 2000-03-02 2002-08-30 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
FR2806005B1 (fr) * 2000-03-10 2002-06-14 Univ Claude Bernard Lyon Procede de preparation de particules colloidales sous forme de nanocapsules
US7153525B1 (en) 2000-03-22 2006-12-26 The University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
WO2001080835A1 (fr) * 2000-04-24 2001-11-01 Tanabe Seiyaku Co., Ltd. Procede de production de microspheres
US20040156872A1 (en) * 2000-05-18 2004-08-12 Elan Pharma International Ltd. Novel nimesulide compositions
US20040033267A1 (en) * 2002-03-20 2004-02-19 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
US7198795B2 (en) 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
DE10047622A1 (de) * 2000-09-26 2002-04-11 Basf Ag Verfahren zur Herstellung von polymerumhüllten Pigmentteilchen durch Präzipitation
AU2002232824A1 (en) † 2000-12-21 2002-07-01 Inhale Therapeutic Systems, Inc. Induced phase transition method for the production of microparticles containing hydrophobic active agents
US6607784B2 (en) * 2000-12-22 2003-08-19 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US6951656B2 (en) * 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20040022862A1 (en) * 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
US7193084B2 (en) * 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US8067032B2 (en) * 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6884436B2 (en) * 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US6977085B2 (en) * 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
DK1345597T3 (da) * 2000-12-27 2007-12-10 Ares Trading Sa Amfifile lipidanopartikler til peptid- og/eller proteininkorporering
WO2003013683A1 (en) * 2001-08-08 2003-02-20 Brown University Research Foundation Methods for micronization of hydrophobic drugs
US20030054042A1 (en) * 2001-09-14 2003-03-20 Elaine Liversidge Stabilization of chemical compounds using nanoparticulate formulations
MXPA04002446A (es) 2001-09-26 2004-07-23 Baxter Int Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
US20060003012A9 (en) * 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8663687B2 (en) * 2001-10-12 2014-03-04 Monosol Rx, Llc Film compositions for delivery of actives
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
CA2469718A1 (en) * 2001-12-10 2003-06-19 Spherics, Inc. Methods and products useful in the formation and isolation of microparticles
US6720008B2 (en) 2002-01-22 2004-04-13 Pr Pharmaceuticals, Inc. Composition and method for the encapsulation of water-soluble molecules into nanoparticles
US20040101566A1 (en) * 2002-02-04 2004-05-27 Elan Pharma International Limited Novel benzoyl peroxide compositions
PT1471887E (pt) 2002-02-04 2010-07-16 Elan Pharma Int Ltd ComposiãŽes de nanopartculas com lisozima como um estabilizador superficial
FR2840532B1 (fr) * 2002-06-11 2005-05-06 Ethypharm Sa Nanocapsules lipidiques furtives, procede de preparation et utilisation comme vecteur de principes(s) actif(s)
EP2283864A1 (en) * 2002-07-16 2011-02-16 Elan Pharma International Ltd. Liquid dosage compositions fo stable nanoparticulate active agents
AU2003302226A1 (en) * 2002-09-24 2004-06-30 University Of Kentucky Research Foundation Nanoparticle-based vaccine delivery system containing adjuvant
WO2004058844A1 (ja) * 2002-12-25 2004-07-15 E-Tec Co., Ltd. 樹脂微粒子及び樹脂マイクロカプセル、並びにそれらの製造方法
WO2005051511A1 (ja) * 2003-11-28 2005-06-09 Mitsubishi Chemical Corporation 有機化合物微粒子の製造方法
FR2864900B1 (fr) 2004-01-09 2007-10-12 Oreal Dispersion aqueuse de nanocapsules a coeur huileux
JP4851067B2 (ja) * 2004-01-28 2012-01-11 ホソカワミクロン株式会社 ナノ粒子含有組成物およびその製造方法
JP2007520555A (ja) * 2004-02-05 2007-07-26 バクスター・インターナショナル・インコーポレイテッド 自己安定化剤の使用により調製された分散剤
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
FR2872703B1 (fr) * 2004-07-07 2006-10-06 Ethypharm Sa Nanoparticules polymeriques composites
FR2879476B1 (fr) * 2004-12-21 2007-04-20 Univ Claude Bernard Lyon Nouveau procede de preparation de particules dont au moins la surface peripherique est de nature polymerique, mettant en oeuvre un reacteur membranaire
US7824691B2 (en) * 2005-04-04 2010-11-02 Centegen, Inc. Use of RIP in treating staphylococcus aureus infections
EP1906985A4 (en) * 2005-05-10 2012-07-11 Naomi Balaban COMPOSITIONS FOR ADMINISTERING RNAIII-INHIBITING PEPTIDES
US20070059370A1 (en) * 2005-09-15 2007-03-15 Industrial Technology Research Institute Method and apparatus for fabricating nanoparticles
JP2009508936A (ja) * 2005-09-20 2009-03-05 イッサム リサーチ ディベロップメント カンパニー 活性物質の標的化送達用ナノ粒子
US9393215B2 (en) * 2005-12-02 2016-07-19 Novartis Ag Nanoparticles for use in immunogenic compositions
US20080026217A1 (en) * 2005-12-02 2008-01-31 Kim Hye M Method for preparing a photochromic nanoparticle and nanoparticle prepared therefrom
DE102006005165A1 (de) * 2006-02-04 2007-08-09 Bayer Materialscience Ag Verfahren zur Herstellung von Lithium-Molybdat-Nanopartikeln
US20100119827A1 (en) * 2006-04-25 2010-05-13 Research Foundation Of The City University Of New York Polymer submicron particle preparation by surfactant-mediated precipitation
FR2910284B1 (fr) * 2006-12-20 2009-04-17 Oreal Produit cosmetique comprenant des composes silicones et un polymere amphiphile
FR2910286B1 (fr) 2006-12-20 2009-04-17 Oreal Composition comprenant des composes silicones encapsules
FR2910345A1 (fr) 2006-12-20 2008-06-27 Oreal Particules coeur/ecorce a base de composes silicones
FR2910294B1 (fr) * 2006-12-20 2009-04-17 Oreal Emulsion cosmetique contenant des composes silicones
US20100290982A1 (en) * 2007-04-13 2010-11-18 University Of North Texas Health Science Center At Fort Worth Solid in oil/water emulsion-diffusion-evaporation formulation for preparing curcumin-loaded plga nanoparticles
AU2008240155B2 (en) * 2007-04-13 2012-09-20 University Of North Texas Health Science Center At Fort Worth Formulation of active agent loaded activated PLGA nanoparticles for targeted cancer nano-therapeutics
WO2008135828A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
US8703204B2 (en) 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
EP2162120B1 (en) 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
FR2918296B1 (fr) 2007-07-05 2009-09-18 Oreal Capsules de type noyau/ecorce et procede de preparation
US20090119321A1 (en) * 2007-11-02 2009-05-07 International Business Machines Corporation Methods and computer program products for implementing low-cost pointer compression and decompression
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
EP2240162A4 (en) 2007-12-06 2013-10-09 Bend Res Inc NANOTE PARTICLES WITH A NON-IONIZABLE POLYMER AND AN AMIN-FUNCTIONALIZED METHACRYLATE COPOLYMER
JP5247180B2 (ja) 2008-02-13 2013-07-24 富士フイルム株式会社 インクジェット記録用水性インク及びその製造方法
JP2009191133A (ja) 2008-02-13 2009-08-27 Fujifilm Corp インクジェット記録用水性インク
JP4668305B2 (ja) 2008-02-29 2011-04-13 富士フイルム株式会社 水系着色剤分散物、水系着色剤分散物の製造方法、及びインクジェット記録用水系インク
EP2106806A1 (en) 2008-03-31 2009-10-07 Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. Nanoparticles for targeted delivery of active agents to the lung
WO2009134769A1 (en) * 2008-04-28 2009-11-05 Novartis Ag Nanoparticles for use in pharmaceutical compositions
FR2933614B1 (fr) 2008-07-10 2010-09-10 Oreal Kit de protection solaire.
CA2730760A1 (en) * 2008-07-16 2010-01-21 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles containing bioactive peptides
CA2765112A1 (en) 2009-06-10 2010-12-16 Novartis Ag Benzonaphthyridine-containing vaccines
ES2384060B1 (es) * 2010-03-24 2013-09-23 Lipotec S.A. Cápsulas de nanopartículas lipídicas.
US8207290B2 (en) 2010-03-26 2012-06-26 Cerulean Pharma Inc. Methods and systems for generating nanoparticles
CN102933267B (zh) 2010-05-28 2015-05-27 泰特里斯在线公司 交互式混合异步计算机游戏基础结构
BRPI1001959A2 (pt) * 2010-06-15 2012-03-06 Instituto De Pesquisas Tecnológicas Do Est. S. Paulo S/a - Ipt Nanocarreadores coloidais para ativos hidrofílicos e processo de produção
US9192661B2 (en) 2010-07-06 2015-11-24 Novartis Ag Delivery of self-replicating RNA using biodegradable polymer particles
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
FR2967573B1 (fr) 2010-11-23 2012-11-09 Rhodia Poliamida E Especialidades Ltda Kit cosmetique et utilisation pour ameliorer l'aspect de la peau
US8546521B2 (en) 2011-01-28 2013-10-01 Cerulean Pharma Inc. Method for fabricating nanoparticles
EP2723452A2 (en) 2011-06-22 2014-04-30 Vyome Biosciences Pvt Ltd Conjugate-based antifungal and antibacterial prodrugs
BRPI1106302B1 (pt) * 2011-10-24 2021-11-23 Fundação De Amparo À Pesquisa De Est. De Minas Gerais-Fapeming Composições farmacêuticas de suspensões de nanocápsulas contendo licnofolida para tratamento de infecções parasitárias e de tumores
RU2543633C2 (ru) * 2012-08-28 2015-03-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ инкапсуляции фенбендазола
RU2544169C2 (ru) * 2013-04-09 2015-03-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ инкапсуляции интестевита
RU2544166C2 (ru) * 2013-05-14 2015-03-10 Александр Александрович Кролевец Способ получения микрокапсул оксида цинка
RU2539898C2 (ru) * 2013-05-14 2015-01-27 Александр Александрович Кролевец Способ биоинкапсуляции лекарственных препаратов группы цефалоспоринов
RU2545752C2 (ru) * 2013-05-17 2015-04-10 Екатерина Евгеньевна Быковская Способ микрокапсулирования цефалоспориновых антибиотиков в полудане
RU2554277C2 (ru) * 2013-05-20 2015-06-27 Александр Александрович Кролевец Способ биоинкапсуляции лекарственных препаратов группы цефалоспоринов
RU2543328C2 (ru) * 2013-05-21 2015-02-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Юго-Западный государственный университет" (ЮЗ ГУ) Способ получения частиц инкапсулированных жирорастворимой полимерной оболочкой ароматизаторов, обладающих супрамолекулярными свойствами
RU2540479C2 (ru) * 2013-05-24 2015-02-10 Александр Александрович Кролевец Способ инкапсуляции фенбендазола
RU2543337C2 (ru) * 2013-05-29 2015-02-27 Екатерина Евгеньевна Быковская Способ инкапсуляции фенбендазола
RU2557939C2 (ru) * 2013-07-05 2015-07-27 Александр Александрович Кролевец Способ получения микрокапсул ароматизаторов "вишня" и "томат", обладающих супрамолекулярными свойствами
RU2546516C2 (ru) * 2013-07-08 2015-04-10 Александр Александрович Кролевец Способ получения микрокапсул лекарственных препаратов группы пенициллинов в каппа-карагинане
RU2557950C2 (ru) * 2013-12-17 2015-07-27 Александр Александрович Кролевец Способ получения микрокапсул антиоксидантов
RU2554783C1 (ru) * 2014-03-03 2015-06-27 Александр Александрович Кролевец Способ получения нанокапсул албендазола
EP3138556B1 (en) 2014-04-30 2022-03-02 FUJIFILM Corporation Method for producing liposomes
RU2578403C2 (ru) * 2014-05-12 2016-03-27 Александр Александрович Кролевец Способ получения нанокапсул цитокининов
RU2577692C1 (ru) * 2014-09-09 2016-03-20 Александр Александрович Кролевец Способ получения нанокапсул флаваноидов шиповника
RU2577685C1 (ru) * 2014-09-19 2016-03-20 Александр Александрович Кролевец Способ получения нанокапсул лозартана калия в альгинате натрия
RU2607654C2 (ru) * 2014-10-10 2017-01-10 Александр Александрович Кролевец Способ получения нанокапсул аденина в каррагинане
RU2605848C2 (ru) * 2014-10-10 2016-12-27 Александр Александрович Кролевец Способ получения нанокапсул лекарственных препаратов группы цефалоспоринов в интерфероне
IL296875A (en) 2014-12-31 2022-12-01 Lantheus Medical Imaging Inc Fat-wrapped gas microsphere preparations and related methods
RU2596476C1 (ru) * 2015-04-27 2016-09-10 Александр Александрович Кролевец Способ получения нанокапсул лекарственных растений, обладающих спазмолитическим действием
EP3303286B1 (en) 2015-06-01 2023-10-04 Cedars-Sinai Medical Center Compounds that bind to rela of nf-kb for use in treating cancer
US10087326B2 (en) 2016-02-29 2018-10-02 Michelman, Inc. Aqueous-based hydrolytically stable dispersion of a biodegradable polymer
CA3022698A1 (en) 2016-05-04 2017-11-09 Lantheus Medical Imaging, Inc. Methods and devices for preparation of ultrasound contrast agents
CN122182527A (zh) 2016-05-05 2026-06-12 阿奎斯蒂弗医疗股份有限公司 增强递送的肾上腺素组合物
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
EP3586827A1 (en) 2018-06-29 2020-01-01 Consejo Superior de Investigaciones Cientificas (CSIC) Pharmaceutical formulation with improved solubility and bioavailability
FR3110427B1 (fr) 2020-05-20 2023-07-14 Laboratoires Eriger Conjugué terpenique de couplage
WO2023076281A1 (en) 2021-10-25 2023-05-04 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment
WO2023183082A1 (en) 2022-03-24 2023-09-28 The Regents Of The University Of California Silyl lipids suitable for enhanced delivery of anti-viral therapeutics
KR20240163740A (ko) 2022-03-30 2024-11-19 에보니크 오퍼레이션즈 게엠베하 세포 내로의 폴리뉴클레오티드의 전달을 위한 양이온성 지질 및 폴리(락틱-코-글리콜산)로 구성된 제제

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH201942A (de) * 1935-07-08 1938-12-31 A Dr Krause Georg Verfahren zur Herstellung von Solen bezw. Suspensionen organischer Substanzen.
DE738604C (de) * 1935-07-09 1943-08-23 Rudolf Degkwitz Dr Verfahren zur Herstellung von Hydrosolen mit waehlbarer Gestalt und waehlbarer Groesse der kolloiden Teilchen
US3242051A (en) * 1958-12-22 1966-03-22 Ncr Co Coating by phase separation
US3069370A (en) * 1958-12-22 1962-12-18 Upjohn Co Coacervation process for encapsulation of lipophilic materials
US3748277A (en) * 1965-10-14 1973-07-24 Ncr Co Process of forming minute capsules
US3657144A (en) * 1967-06-05 1972-04-18 Ncr Co Encapsulation process
BE717134A (enExample) * 1968-08-05 1968-12-27
BE744162A (fr) * 1969-01-16 1970-06-15 Fuji Photo Film Co Ltd Procede d'encapsulage
US3664963A (en) * 1969-10-22 1972-05-23 Balchem Corp Encapsulation process
US3780195A (en) * 1969-10-22 1973-12-18 Balchem Corp Encapsulation process
US4016099A (en) * 1972-03-27 1977-04-05 Xerox Corporation Method of forming encapsulated toner particles
CH594444A5 (enExample) * 1972-12-04 1978-01-13 Gerd Birrenbach
US4118336A (en) * 1974-03-25 1978-10-03 Toyo Jozo Company, Ltd. Novel cellulose microcapsules and preparation thereof
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
GB1497161A (en) * 1975-07-19 1978-01-05 Beecham Group Ltd Naphthyl derivatives
GB1524307A (en) * 1976-06-16 1978-09-13 Monsanto Europe Sa Encapsulation process
US4585651A (en) * 1978-10-17 1986-04-29 Stolle Research & Development Corporation Active/passive immunization of the internal female reproductive organs
IT1148784B (it) * 1980-04-09 1986-12-03 Eurand Spa Procedimento per la preparazione di microcapsule in un veicolo liquido
US4637905A (en) * 1982-03-04 1987-01-20 Batelle Development Corporation Process of preparing microcapsules of lactides or lactide copolymers with glycolides and/or ε-caprolactones
US4608278A (en) * 1983-06-22 1986-08-26 The Ohio State University Research Foundation Small particule formation and encapsulation
US4492720A (en) * 1983-11-15 1985-01-08 Benjamin Mosier Method of preparing microspheres for intravascular delivery
US4606940A (en) * 1984-12-21 1986-08-19 The Ohio State University Research Foundation Small particle formation and encapsulation

Also Published As

Publication number Publication date
ATE74025T1 (de) 1992-04-15
JPH0693998B2 (ja) 1994-11-24
FR2608942A1 (fr) 1988-07-01
DE3777793D1 (de) 1992-04-30
GR3004198T3 (enExample) 1993-03-31
JPS63232840A (ja) 1988-09-28
CA1293170C (en) 1991-12-17
EP0274961B1 (fr) 1992-03-25
US5049322A (en) 1991-09-17
FR2608942B1 (fr) 1991-01-11
EP0274961A1 (fr) 1988-07-20

Similar Documents

Publication Publication Date Title
GR3004198T3 (enExample)
GR3004152T3 (en) Preparation process for disperse colloidal systems from a substance in the shape of nanoparticles.
EP0270460A3 (en) Microcrystals containing an active substance with a phospholipid affinity and at least a phospholipid; preparation process
BR9205208A (pt) Processo para a preparacao de uma suspensao aquosa,composicao e uso
GR77128B (enExample)
GB1539625A (en) Process for preparing aqueous dispersions of lipid spherules and aqueous dispersions of such lipid spherules
ATE77946T1 (de) Injizierbares langwirkendes mikroteilchenpr|parat zur verabreichung entzuendungshemmender mittel.
DE3367517D1 (en) Microcapsules with walls formed of a mixture of reticulated polyholosides and proteins, and process for producing them
NO165596C (no) Fremgangsmaate for fremstilling av smaa, sfaeriske polymerpartikler.
FR2692168B1 (fr) Préparation et utilisation de nouveaux systèmes colloïdaux dispersibles à base de cyclodextrine, sous forme de nanosphères.
ATE8743T1 (de) Verfahren zur herstellung von strukturen aus lipoiden membranen.
ATE66684T1 (de) Verfahren zur herstellung einer polysaccharid-in- oel-dispersion und so hergestellte dispersion.
FR2806005B1 (fr) Procede de preparation de particules colloidales sous forme de nanocapsules
RU94046375A (ru) Составы жидкого моющего средства, обусловливающие устойчивую пену и способ их приготовления
AU7379687A (en) A process for obtaining active proteins from a biologically inactive form
ES2083291T3 (es) Preparacion y aplicacion de nuevos sistemas coloidales nanovesiculares dispersables a base de ciclodextrina, en forma de nanocapsulas.
JPH04300897A (ja) 絹フィブロイン溶液
ATE49767T1 (de) Verfahren zur herstellung von sphaerischen teilchen von metallverbindungen der zweiten gruppe.
SU1409036A1 (ru) Способ получения тонких дисперсий защищаемых цветных компонент
JPS55164189A (en) Process for preparing microcapsule dispersing liquid
FI852656L (fi) Foerfarande foer framstaellning av partiklar av samma storlek ur vaetskeoloesliga organiska foereningar.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 274961

Country of ref document: ES